MSH2 Antibody - #BF0300
Product Info
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
Cite Format: Affinity Biosciences Cat# BF0300, RRID:AB_2833498.
Fold/Unfold
BAT26; COCA 1; COCA1; DNA mismatch repair protein Msh2; FCC 1; FCC1; hMSH2; HNPCC 1; HNPCC; HNPCC1; LCFS2; MSH 2; Msh2; MSH2_HUMAN; MutS homolog 2; MutS homolog 2 colon cancer nonpolyposis type 1; MutS protein homolog 2;
Immunogens
Purified recombinant fragment of human MSH2 expressed in E. Coli.
- P43246 MSH2_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MAVQPKETLQLESAAEVGFVRFFQGMPEKPTTTVRLFDRGDFYTAHGEDALLAAREVFKTQGVIKYMGPAGAKNLQSVVLSKMNFESFVKDLLLVRQYRVEVYKNRAGNKASKENDWYLAYKASPGNLSQFEDILFGNNDMSASIGVVGVKMSAVDGQRQVGVGYVDSIQRKLGLCEFPDNDQFSNLEALLIQIGPKECVLPGGETAGDMGKLRQIIQRGGILITERKKADFSTKDIYQDLNRLLKGKKGEQMNSAVLPEMENQVAVSSLSAVIKFLELLSDDSNFGQFELTTFDFSQYMKLDIAAVRALNLFQGSVEDTTGSQSLAALLNKCKTPQGQRLVNQWIKQPLMDKNRIEERLNLVEAFVEDAELRQTLQEDLLRRFPDLNRLAKKFQRQAANLQDCYRLYQGINQLPNVIQALEKHEGKHQKLLLAVFVTPLTDLRSDFSKFQEMIETTLDMDQVENHEFLVKPSFDPNLSELREIMNDLEKKMQSTLISAARDLGLDPGKQIKLDSSAQFGYYFRVTCKEEKVLRNNKNFSTVDIQKNGVKFTNSKLTSLNEEYTKNKTEYEEAQDAIVKEIVNISSGYVEPMQTLNDVLAQLDAVVSFAHVSNGAPVPYVRPAILEKGQGRIILKASRHACVEVQDEIAFIPNDVYFEKDKQMFHIITGPNMGGKSTYIRQTGVIVLMAQIGCFVPCESAEVSIVDCILARVGAGDSQLKGVSTFMAEMLETASILRSATKDSLIIIDELGRGTSTYDGFGLAWAISEYIATKIGAFCMFATHFHELTALANQIPTVNNLHVTALTTEETLTMLYQVKKGVCDQSFGIHVAELANFPKHVIECAKQKALELEEFQYIGESQGYDIMEPAAKKCYLEREQGEKIIQEFLSKVKQMPFTEMSEENITIKLKQLKAEVIAKNNSFVNEIISRIKVTT
PTMs - P43246 As Substrate
Site | PTM Type | Enzyme | Source |
---|---|---|---|
A2 | Acetylation | Uniprot | |
K65 | Ubiquitination | Uniprot | |
Y66 | Phosphorylation | Uniprot | |
K73 | Acetylation | Uniprot | |
K73 | Ubiquitination | Uniprot | |
S77 | Phosphorylation | Uniprot | |
K104 | Acetylation | Uniprot | |
K104 | Methylation | Uniprot | |
K113 | Acetylation | Uniprot | |
K172 | Ubiquitination | Uniprot | |
T206 | Phosphorylation | Uniprot | |
K212 | Ubiquitination | Uniprot | |
R219 | Methylation | Uniprot | |
K235 | Ubiquitination | Uniprot | |
Y238 | Phosphorylation | Uniprot | |
K249 | Ubiquitination | Uniprot | |
K332 | Ubiquitination | Uniprot | |
K347 | Ubiquitination | Uniprot | |
K430 | Sumoylation | Uniprot | |
S479 | Phosphorylation | Uniprot | |
K491 | Ubiquitination | Uniprot | |
K509 | Ubiquitination | Uniprot | |
K531 | Ubiquitination | Uniprot | |
K537 | Ubiquitination | Uniprot | |
K550 | Acetylation | Uniprot | |
K555 | Acetylation | Uniprot | |
K555 | Ubiquitination | Uniprot | |
S558 | Phosphorylation | Uniprot | |
Y563 | Phosphorylation | Uniprot | |
K565 | Ubiquitination | Uniprot | |
K567 | Ubiquitination | Uniprot | |
Y570 | Phosphorylation | Uniprot | |
K635 | Acetylation | Uniprot | |
K635 | Ubiquitination | Uniprot | |
S717 | Phosphorylation | Uniprot | |
K720 | Ubiquitination | Uniprot | |
S738 | Phosphorylation | Uniprot | |
T740 | Phosphorylation | Uniprot | |
K741 | Ubiquitination | Uniprot | |
S743 | Phosphorylation | Uniprot | |
K845 | Ubiquitination | Uniprot | |
S860 | Phosphorylation | Uniprot | |
Y863 | Phosphorylation | Uniprot | |
K871 | Ubiquitination | Uniprot | |
K872 | Ubiquitination | Uniprot | |
K882 | Ubiquitination | Uniprot | |
K892 | Ubiquitination | Uniprot | |
T897 | Phosphorylation | Uniprot | |
S900 | Phosphorylation | Uniprot | |
K912 | Ubiquitination | Uniprot | |
K918 | Ubiquitination | Uniprot | |
S921 | Phosphorylation | Uniprot |
Research Backgrounds
Component of the post-replicative DNA mismatch repair system (MMR). Forms two different heterodimers: MutS alpha (MSH2-MSH6 heterodimer) and MutS beta (MSH2-MSH3 heterodimer) which binds to DNA mismatches thereby initiating DNA repair. When bound, heterodimers bend the DNA helix and shields approximately 20 base pairs. MutS alpha recognizes single base mismatches and dinucleotide insertion-deletion loops (IDL) in the DNA. MutS beta recognizes larger insertion-deletion loops up to 13 nucleotides long. After mismatch binding, MutS alpha or beta forms a ternary complex with the MutL alpha heterodimer, which is thought to be responsible for directing the downstream MMR events, including strand discrimination, excision, and resynthesis. Recruits DNA helicase MCM9 to chromatin which unwinds the mismatch containing DNA strand. ATP binding and hydrolysis play a pivotal role in mismatch repair functions. The ATPase activity associated with MutS alpha regulates binding similar to a molecular switch: mismatched DNA provokes ADP-->ATP exchange, resulting in a discernible conformational transition that converts MutS alpha into a sliding clamp capable of hydrolysis-independent diffusion along the DNA backbone. This transition is crucial for mismatch repair. MutS alpha may also play a role in DNA homologous recombination repair. In melanocytes may modulate both UV-B-induced cell cycle regulation and apoptosis.
Phosphorylated by PRKCZ, which may prevent MutS alpha degradation by the ubiquitin-proteasome pathway.
Nucleus. Chromosome.
Ubiquitously expressed.
Component of the DNA mismatch repair (MMR) complex composed at least of MSH2, MSH3, MSH6, PMS1 and MLH1. Heterodimer consisting of MSH2-MSH6 (MutS alpha) or MSH2-MSH3 (MutS beta). Both heterodimers form a ternary complex with MutL alpha (MLH1-PMS1). Interacts with MCM9; the interaction recruits MCM9 to chromatin. Interacts with MCM8. Interacts with EXO1. Part of the BRCA1-associated genome surveillance complex (BASC), which contains BRCA1, MSH2, MSH6, MLH1, ATM, BLM, PMS2 and the RAD50-MRE11-NBS1 protein complex. This association could be a dynamic process changing throughout the cell cycle and within subnuclear domains. Interacts with ATR. Interacts with SLX4/BTBD12; this interaction is direct and links MutS beta to SLX4, a subunit of different structure-specific endonucleases. Interacts with SMARCAD1.
Belongs to the DNA mismatch repair MutS family.
Research Fields
· Genetic Information Processing > Replication and repair > Mismatch repair.
· Human Diseases > Drug resistance: Antineoplastic > Platinum drug resistance.
· Human Diseases > Cancers: Overview > Pathways in cancer. (View pathway)
· Human Diseases > Cancers: Specific types > Colorectal cancer. (View pathway)
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.